HOME >> BIOLOGY >> NEWS
Protein stops blood-vessel growth, holds promise as cancer therapy

Researchers at National Jewish Medical and Research Center have identified a protein that inhibits the formation of new blood vessels.

Combined with previous findings that the protein is depleted or missing in a majority of metastatic human cancers, the findings suggest that fibulin-5 may one day be an effective cancer therapy. William Schiemann, Ph.D., Assistant Professor in the Program in Cell Biology at National Jewish, and postdoctoral fellow Allan R. Albig reported their findings in the June issue of DNA and Cell Biology.

"We believe fibulin-5 shows real promise as a cancer therapy," said Schiemann. "When we slightly altered the naturally occurring protein it was even more effective at inhibiting the sprouting of new blood vessels."

Cancer tumors need nutrients and oxygen supplied by blood vessels in order to grow. They also use blood vessels to spread to other parts of the body.

This process, known as metastasis, is the most lethal characteristic of cancer and the leading cause of cancer-related death. The strategy of fighting cancer by preventing the growth of new blood vessels has generated great interest in recent years, with the first antiangiogenic drug being approved earlier this year.

Endothelial cells have been the target of most antiangiogenic strategies. Endothelial cells are specialized cells that develop into blood vessels. Fibulin-5, a member of a family of extracellular matrix proteins that regulate tissue development, remodeling and repair, interacts with endothelial cells.

In cell culture studies, Schiemann and Albig showed fibulin-5 levels drop significantly when endothelial cells begin to form blood vessels, a process known as tubulation. They also show that high levels of fibulin-5 could prevent the sprouting of new blood vessels by inhibiting the proliferation and movement of endothelial cells.

Fibulin-5 interfered with signaling by the proangiogenic factor VEGF, and increased level
'"/>

Contact: William Allstetter
allstetterw@njc.org
303-398-1002
National Jewish Medical and Research Center
18-Jun-2004


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Proteins transform DNA into molecular velcro
11. Protein engineered to detect nerve gas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... ... 23, 2020 , ... GIOSTAR/HEAMGEN has developed and ... The red blood cells are made utilizing a bioreactor that permits the ... and replaces the need for a human blood donor. GIOSTAR/HEAMGEN mature ...
(Date:1/22/2020)... ... January 21, 2020 , ... Lifecycle Biotechnologies announces the new line of high purity ... needs based on their process requirements and accurately weighed to 0.001 of a gram. The ... Salts , Sugars , Carbohydrates , Phosphates , ...
(Date:1/7/2020)... Texas (PRWEB) , ... January 07, 2020 , ... ... 2020 prospectus. The Lifecycle prospectus features not just part numbers like what can ... manufacturing facilities, the industries it supports, and that is all linked to the ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... , ... January 24, 2020 , ... ... their RedySmart™ mass flow meters and controllers ideal for BioPharm OEMS. ... ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical ...
(Date:1/22/2020)... (PRWEB) , ... January 21, 2020 , ... QCDx ... liquid biopsy from a simple blood draw, today announced the sale of the proprietary ... The Rare Scope will be used in clinical cancer research. , “The RareScope can ...
(Date:1/8/2020)... ... January 08, 2020 , ... RMA of ... and individuals grow their family, has announced that five of their Board-Certified reproductive ... Since 1991, the renowned publishing company Castle Connolly has compiled the ...
(Date:1/7/2020)... ... January 06, 2020 , ... ... cohort of emerging biosciences ventures invited to participate in the annual program. Twelve ... fundable business plans and a professional network. All startups will receive an entrepreneur ...
Breaking Biology Technology:
Cached News: